STAT | Reporting from the frontiers of health and medicine
www.statnews.com
Santé Bien-être
STAT+: Health insurers score major win with higher 2027 Medicare Advantage rates
Santé Bien-être
STAT+: Pharma companies and patient groups seek to exempt orphan drugs from Colorado pricing limits
Santé Bien-être
STAT+: A key Medicare Advantage announcement is due today
Santé Bien-être
STAT+: Pharmalittle: We’re reading about an FDA delay forcing a biotech to close, a Neurocrine deal, and more
Santé Bien-être
STAT+: Stealth biotech Stipple bets on secretive ADCs
Santé Bien-être
UnitedHealth makes a bet on AI. What does it mean for us?
Santé Bien-être
STAT+: Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B deal
Santé Bien-être
Opinion: ‘Medical nutrition’ helps keep my son, and many others, healthy. But insurance won’t cover it
Santé Bien-être
STAT+: UnitedHealth Group is making a $3 billion bet on AI. What does it mean for patients?
Santé Bien-être
STAT+: How a four-month FDA delay forced a small biotech company to close its doors
Santé Bien-être
What the peptide craze reveals about Americans’ relationship with risk
Santé Bien-être
Opinion: When my child is in psychosis, the pediatric health care system can’t help us
Santé Bien-être
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Santé Bien-être
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Santé Bien-être
STAT+: Up and down the ladder: The latest comings and goings
Santé Bien-être
STAT+: Biotech investors’ plea to Trump, and a busy M&A week
Santé Bien-être
STAT+: Pharmalittle: We’re reading about Trump’s drug tariffs, a U.S.-U.K. pharma trade deal, and more
Santé Bien-être
Thursday was World Autism Awareness Day. HHS celebrated with…a workout?
Santé Bien-être
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Santé Bien-être
Opinion: My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine
Santé Bien-être
Supreme Court conversion therapy decision could ripple through medicine
Santé Bien-être
STAT+: Medicare Advantage plans win extra $18.6 billion as feds cut star ratings measures
Santé Bien-être
EPA to put microplastics on study list of contaminants in drinking water
Santé Bien-être
STAT+: Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House
Santé Bien-être
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Santé Bien-être
Biotech investors’ plea to Trump, and a busy M&A week
Santé Bien-être
STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Santé Bien-être
STAT+: How health care could gum up Trump’s reconciliation push
Santé Bien-être
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Santé Bien-être
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Santé Bien-être
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Santé Bien-être
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Santé Bien-être
Opinion: Medical misinformation wins when patients can’t see their doctors
Santé Bien-être
Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?
Santé Bien-être
STAT reporter goes up against radiologists to spot deepfake X-rays
Santé Bien-être
Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Santé Bien-être
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Santé Bien-être
STAT+: Makary marks one year at FDA with focus on achievements in speech to staff
Santé Bien-être
STAT+: Large AI scribe study finds modest time savings, inconsistent use
Santé Bien-être
STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Santé Bien-être
Opinion: Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene
Santé Bien-être
Opinion: Medical marijuana should not be recommended for PTSD, anxiety, or depression
Santé Bien-être
Why an ovary syndrome may get a new name: Men seem to have PCOS, too
Santé Bien-être
STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch
Santé Bien-être
STAT+: NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback
Santé Bien-être
STAT+: Can a psychedelic ‘coach’ make ketamine therapy even more effective?
Santé Bien-être
STAT+: The HSA industry makes its MAHA pitch
Santé Bien-être
STAT+: HHS changes the U.S. health IT office’s name, and its purview
Santé Bien-être